Megestrol Acetate NCD Oral Suspension - Par Pharmaceutical: Megestrol Acetate NanoCrystal® Dispersion Oral Suspension, PAR 100.2, PAR-100.21 1 This profile replaces the profile published in Drugs in R&D 2007; 8 (4): 251-4.

By Adis International Limited  

Drugs in R&D, Vol. 8, Iss. 6, 2007-01 ,pp. : 403-406

Adis International

Access to resources Recommend Favorite

Eslicarbazepine Acetate (BIA 2-093): Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations

By Fontes-Ribeiro Carlos  

Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite

Nomegestrol Acetate/Estradiol: In Oral Contraception

By Yang Lily P.H.   Plosker Greg L.  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1917-1928

Adis International

Access to resources Recommend Favorite

Enhancement of oral absorption of metronidazole suspension in humans

By Idkaidek N.M.   Najib N.M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 2, 2000-09 ,pp. : 213-216

Elsevier

Access to resources Recommend Favorite

Fexofenadine in pediatrics: oral tablet and suspension formulations

By Mansfield Lyndon E  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 329-337

Informa Healthcare

Access to resources Recommend Favorite